Silvia Codenotti Selected Research

Reactive Oxygen Species (Oxygen Radicals)

1/2022	Radioresistance in rhabdomyosarcomas: Much more than a question of dose.
8/2020	Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization.
4/2019	NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia Codenotti Research Topics

Disease

17	Neoplasms (Cancer) 12/2023 - 01/2014
15	Rhabdomyosarcoma 02/2024 - 01/2014
8	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 01/2014
3	Embryonal Rhabdomyosarcoma 01/2022 - 01/2019
3	Liposarcoma 11/2017 - 08/2016
2	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2019
2	Alveolar Rhabdomyosarcoma 04/2019 - 09/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2019
1	Hypoxia (Hypoxemia) 03/2017
1	Hypertrophy 08/2016

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2015
5	Caveolin 1IBA 02/2024 - 01/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2019
3	Histone Deacetylase InhibitorsIBA 10/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2016
2	AntioxidantsIBA 01/2020 - 04/2019
2	givinostat hydrochlorideIBA 01/2019 - 01/2019
2	givinostatIBA 01/2019 - 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024
1	erdafitinibIBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2023
1	Dextrans (Dextran)FDA Link 10/2023
1	IronIBA 10/2023
1	Isoflurophate (DFP)FDA Link 10/2023
1	Polyamine OxidaseIBA 01/2023
1	Oncogene Proteins (Oncogene Protein)IBA 10/2022
1	oleandrinIBA 01/2022
1	PBI-05204IBA 01/2022
1	Mevalonic Acid (Mevalonate)IBA 01/2022
1	entinostat (MS 275)IBA 10/2021
1	romidepsin (FK228)FDA Link 01/2021
1	Cyclin AIBA 01/2021
1	CytokinesIBA 08/2020
1	belinostatIBA 10/2019
1	Hydroxamic Acids (Hydroxamic Acid)IBA 10/2019
1	Radiation-Sensitizing AgentsIBA 10/2019
1	Oxidants (Oxidizing Agents)IBA 04/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2019
1	erastinIBA 09/2018
1	Glutathione (Reduced Glutathione)IBA 09/2018
1	Biomarkers (Surrogate Marker)IBA 03/2017
1	CaveolinsIBA 03/2017
1	Insulin (Novolin)FDA Link 08/2016
1	LipidsIBA 08/2016
1	Caveolin 2IBA 08/2016
1	MelatoninIBA 07/2015
1	Cisplatin (Platino)FDA LinkGeneric 07/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015
1	Caveolin 3IBA 01/2015
1	src-Family KinasesIBA 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2014

Therapy/Procedure

4	Therapeutics 10/2023 - 01/2022
4	Radiotherapy 01/2022 - 04/2019
1	Intravenous Injections 01/2019
1	Heterologous Transplantation (Xenotransplantation) 01/2014